Cross Contamination, Infection Risk From Arthroscopy Pump Tubing Sets Results in FDA Guidance

The FDA has issued new draft guidance intended to address the risk of cross contamination from arthroscopy pump tubing sets, which may lead to backflow that transfers infections to multiple patients.

In a Draft Guidance Premarket Notification for Arthroscopy Pump Tubing Sets issued on January 28, federal regulators outline a number of recommendations for 510(k) submissions for approval of new devices, which are intended for use on multiple patients. The guidance comes following reports of backflow problems that may have already led to disease transmission with the devices.

An arthroscope is an electrically powered endoscope used to perform joint surgery, and to make the interior of a joint more visible. These are often paired with pump tubing to deliver irrigation fluid to a surgical site, like a knee, shoulder, hip, elbow, ankle and wrist joint cavities during arthroscopic procedures. However, during arthroscopic surgical procedures, doctors often use a single source of irrigation fluid for multiple patients. They often do so without replacing the source of irrigation fluid or replacing or cleaning the irrigation tubing system between patients.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

By not replacing the irrigation source or tubing, this can increase the risk of cross contamination between patients and increase the risk of the irrigation system becoming contaminated with patient fluids during backflow, when it travels back through the irrigation tubing. This can lead to subsequent infection from the patient fluids contaminating the irrigation system.

The draft guidance focuses on device design considerations and risk mitigation strategies. It includes testing recommendations for arthroscopy pump tubing sets intended for multiple patients.

“While FDA believes the recommendations serve as rigorous risk mitigation strategies for reducing the risk of cross-contamination between patients, it should be noted that the only way to eliminate the risk of cross-contamination from multiple patient use is to utilize single patient use arthroscopy pump tubing sets,” FDA officials wrote in a press release.

The draft guidance also clarifies the terminology used to describe arthroscopy pump tubing sets intended for multiple patient use.

The public comment period for the draft guidance will be open until March 30, 2020. Comments intended for the FDA’s consideration to develop the final version must be submitted by that date. Information on how to submit public comments is detailed in the draft guidance.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer
Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer "Representative" (Posted 4 days ago)

Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.